- Ongoing, recruitingTherapeutic exploratory (Phase II)
A Global, Open-label, Adaptive Design Study to Investigate the Efficacy and Safety of SerpinPC in Subjects With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B (PRESent-2)
This study is looking into a new medicine called SerpinPC for severe haemophilia A or B. It wants to see if SerpinPC can reduce bleeding in adults with these conditions, especially those who currently treat bleeds as they happen. Researchers will also check how safe the new medicine is.
For: Severe Hemophilia A or Moderately Severe to Severe Hemophilia BSpain · Germany · Belgium - Ongoing, recruitingTherapeutic exploratory (Phase II)
A Global, Open-label Study to Investigate the Efficacy and Safety of SerpinPC in Subjects With Hemophilia B With Inhibitors (PRESent-3)
This study is looking at a new medicine called SerpinPC for men with a specific type of Haemophilia B who have developed 'inhibitors'. We want to see if SerpinPC can reduce bleeding episodes and if it's safe to use.
For: Hemophilia BSpain · France · Italy